Motaghinejad Majid, Ebrahimzadeh Andia, Shabab Behnaz
Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Solid Dosage Form Department, Iran Hormone Pharmaceutical Company, Tehran, Iran.
Int J Prev Med. 2014 Nov;5(11):1422-31.
Chronic abuse of opiates induces dependency, but the neurobiological mechanisms of this event remain unclear. The aim of this study was to evaluate the effects of intracerebroventricular of venlafaxine on the morphine dependence and pain perception.
A total of 80 adult male rats were divided into two major groups: (1) 40 of them was divided into groups of positive control (morphine dependent) negative control (received saline) and morphine dependent groups under treatment by central administration of venlafaxine at various dosages (25, 50, or 100 μg), after drug treatment total withdrawal index (TWI), latency time of withdrawal syndrome expression and blood cortisol as marker of anxiety were measured and compared with positive control and negative control. (2) Forty rats were grouped in control; indometacin treated (5 mg/kg) and grouped which received central administration of venlafaxine at three doses (25, 50, or 100 μg) and then pain perception and expression was assessed in the writhing test (acetic acid induced abdominal constriction), tail flick, and hot plate test.
Central administration of three doses (25, 50, or 100 μg,) of venlafaxine attenuates TWI to 47 ± 1.2, 38 ± 1.5, and 23 ± 1.1 and decrease blood cortisol level to 14 ± 1, 13.75 ± 0.5, and 12.5 ± 0.8, this decreases was significant in comparison with the positive control group (P < 0.05). Central administration of venlafaxine at mentioned doses significantly attenuates pain response with 37%, 24%, and 20% inhibition in writhing test, 69%, 34%, and 23% inhibition in hot plate test, and 29%, 23%, and 15% inhibition in tail flick test in comparison with control group (P < 0.05).
This study suggested that central administration of venlafaxine attenuated morphine withdrawal index and can be effective in modulation of pain that was induced by morphine dependency.
长期滥用阿片类药物会导致成瘾,但这一过程的神经生物学机制仍不清楚。本研究的目的是评估脑室内注射文拉法辛对吗啡依赖和痛觉的影响。
总共80只成年雄性大鼠被分为两大组:(1)其中40只被分为阳性对照组(吗啡依赖组)、阴性对照组(接受生理盐水)和吗啡依赖组,后者通过脑室内注射不同剂量(25、50或100μg)的文拉法辛进行治疗,药物治疗后测量总戒断指数(TWI)、戒断综合征出现的潜伏期以及作为焦虑指标的血皮质醇水平,并与阳性对照组和阴性对照组进行比较。(2)40只大鼠被分为对照组;吲哚美辛治疗组(5mg/kg)以及接受三种剂量(25、50或100μg)脑室内注射文拉法辛的组,然后在扭体试验(乙酸诱导的腹部收缩)、甩尾试验和热板试验中评估痛觉和痛觉表现。
脑室内注射三种剂量(25、50或100μg)的文拉法辛可使TWI分别降至47±1.2、38±1.5和23±1.1,并使血皮质醇水平分别降至14±1、13.75±0.5和12.5±0.8,与阳性对照组相比,这种降低具有显著性(P<0.05)。与对照组相比,脑室内注射上述剂量的文拉法辛在扭体试验中分别显著减轻疼痛反应37%、24%和20%,在热板试验中分别减轻69%、34%和23%,在甩尾试验中分别减轻29%、23%和15%(P<0.05)。
本研究表明,脑室内注射文拉法辛可降低吗啡戒断指数,并能有效调节吗啡依赖引起的疼痛。